Atlas Trials

Spinal Muscular Atrophy Type I

11 clinical trials · Condition

Sort:Newest firstOldest first

◉ Watch Spinal Muscular Atrophy Type I

RecordFirmDate
Study of Safety, Tolerability and Efficacy of GB221 in Infants With Spinal Muscular Atrophy Type 1 (NCT07070999)Gemma Biotherapeutics2026-01-06
Psychological Evaluation of the Parental Experience of Newborn Screening for Infantile Spinal Muscular Atrophy in the Grand Est and Nouvelle-Aquitaine Regions (NCT07208903)University Hospital, Strasbourg, France2025-10-20
Impact of Motor and Oral Motor Function on Quality of Life in Children With SMA (NCT06864767)Zeynep HOŞBAY2024-05-30
The Effect of Spinal Orthosis on the Development of Scoliosis and Chest Deformity in Type I Spinal Muscular Atrophy (NCT05878418)Medipol University2023-10-11
Therapeutic Management and Use of Resources and Costs of Spinal Muscular Atrophy in Spain (NCT06632730)Novartis2023-07-05
Clinical Trial to Assess the Safety and Efficacy of EXG001-307 in Patients with Spinal Muscular Atrophy Type 1 (NCT05614531)Guangzhou Jiayin Biotech Ltd2023-02-16
Long-term Follow-up Study of Patients Receiving Onasemnogene Abeparvovec-xioi (NCT04042025)Novartis Gene Therapies2020-02-10
Single-Dose Gene Replacement Therapy Using for Patients With Spinal Muscular Atrophy Type 1 With One or Two SMN2 Copies (NCT03837184)Novartis Gene Therapies2019-05-31
Body Weight Support Harness System in Spinal Muscular Atrophy (NCT05715749)Nationwide Children's Hospital2018-09-07
CARNIVAL Type I: Valproic Acid and Carnitine in Infants With Spinal Muscular Atrophy (SMA) Type I (NCT00661453)University of Utah2008-04-01
Clinical Trial of Sodium Phenylbutyrate in Children With Spinal Muscular Atrophy Type I (NCT00439218)Westat2008-01-01

Track Spinal Muscular Atrophy Type I automatically

Every clearance here is in the API, with alerts when new ones post.